|
Clinical
Cancer Research |
|
|
|
Gillian M.
Borthwick, A. Sarah Johnson, Matthew Partington,
John Burn, Robert Wilson and Helen M.
Arthur
Therapeutic levels of aspirin and salicylate directly inhibit a model
of angiogenesis through a Cox-independent mechanism
The FASEB Journal. 2006 Oct;20:2009-2016
|
|
C
Bosetti, S Gallus, C La Vecchia
Aspirin and cancer risk: an update to 2001
European Journal of Cancer Prevention 2002;
11(6):535-542
(Clinical Study,
Abstract)
|
|
Nancy R. Cook, ScD;
I-Min Lee, MBBS, ScD; J. Michael Gaziano, MD; David
Gordon, MA; Paul M Ridker, MD; JoAnn E. Manson, MD,
DrPH; Charles H. Hennekens, MD, DrPH; Julie E. Buring,
ScD
Low-Dose Aspirin in the Primary
Prevention of Cancer. The Women’s Health Study: A Randomized Controlled Trial
JAMA, Vol. 294 No. 1, July 6, 2005, Pages 47-55
|
|
Eric
J. Jacobs, PhD; Michael J. Thun, MD
Low-Dose
Aspirin and Vitamin E. Challenges
and Opportunities in Cancer Prevention
JAMA,
2005;294:105-106; Vol.
294 No. 1, July 6, 2005
|
|
|
|
